Nu Skin Enterprises, Inc. found using ticker (NUS) have now 4 analysts in total covering the stock. The consensus rating is ‘Hold’. The range between the high target price and low target price is between 43 and 38 with a mean TP of 40.25. Given that the stocks previous close was at 40.7 this indicates there is a potential downside of -1.1%. The 50 day MA is 42.45 and the 200 moving average now moves to 41.44. The company has a market cap of $2,034m. You can visit the company’s website by visiting: https://www.nuskin.com
The potential market cap would be $2,012m based on the market concensus.
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
